Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease.
Jacques
J
Serratrice
Brigitte
B
Granel
Patrick
P
Disdier
Pierre-Jean
PJ
Weiller
Bertrand
B
Dussol
D000328:Adult; D000686:Amyloidosis / Q000150:complications*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000150:complications*; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016706:Still's Disease, Adult-Onset / Q000150:complications*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept